ATOS - Atossa Therapeutics regains compliance with Nasdaq minimum bid price listing requirements
2024-03-18 08:40:31 ET
More on Atossa Therapeutics
- Atossa spikes as H.C. Wainwright starts at Buy on lead asset
- Seeking Alpha’s Quant Rating on Atossa Therapeutics
- Historical earnings data for Atossa Therapeutics
- Financial information for Atossa Therapeutics